Universe Pharmaceuticals Inc (UPC)
2.15
-0.02
(-0.92%)
USD |
NASDAQ |
May 03, 16:00
2.03
-0.12
(-5.58%)
After-Hours: 20:00
Universe Pharmaceuticals Total Assets (Quarterly): 53.29M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 53.29M |
| March 31, 2023 | 70.37M |
| March 31, 2023 | 70.37M |
| September 30, 2022 | 59.54M |
| March 31, 2022 | 71.37M |
| March 31, 2022 | 71.37M |
| September 30, 2021 | 70.14M |
| Date | Value |
|---|---|
| March 31, 2021 | 67.27M |
| March 31, 2021 | 67.27M |
| September 30, 2020 | 28.80M |
| March 31, 2020 | 26.78M |
| March 31, 2020 | 26.78M |
| September 30, 2019 | 17.84M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
17.84M
Minimum
Sep 2019
71.37M
Maximum
Mar 2022
53.94M
Average
67.27M
Median
Mar 2021
Total Assets (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 13.66B |
| CASI Pharmaceuticals Inc | 75.27M |
| Zai Lab Ltd | 1.036B |
| I-MAB | 368.62M |
| Gracell Biotechnologies Inc (DELISTED) | 259.03M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.75M |
| Shareholders Equity (Quarterly) | 39.53M |
| Debt to Equity Ratio | 0.1387 |
| Current Ratio | 2.676 |
| Net Debt Paydown Yield | -10.32% |